THYROSAFE Drug Patent Profile
✉ Email this page to a colleague
When do Thyrosafe patents expire, and when can generic versions of Thyrosafe launch?
Thyrosafe is a drug marketed by Btg Intl and is included in one NDA.
The generic ingredient in THYROSAFE is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thyrosafe
A generic version of THYROSAFE was approved as potassium iodide by MISSION PHARMACAL on March 24th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THYROSAFE?
- What are the global sales for THYROSAFE?
- What is Average Wholesale Price for THYROSAFE?
Summary for THYROSAFE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 212 |
| Patent Applications: | 3,442 |
| DailyMed Link: | THYROSAFE at DailyMed |
US Patents and Regulatory Information for THYROSAFE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Btg Intl | THYROSAFE | potassium iodide | TABLET;ORAL | 076350-001 | Sep 10, 2002 | OTC | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
